NCCN Practice Guidelines for Chronic Myelogenous Leukemia

Oncology (Williston Park). 2000 Nov;14(11A):229-40.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Marrow Transplantation
  • Combined Modality Therapy
  • Humans
  • Interferon-alpha / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / therapy
  • Monitoring, Physiologic
  • Recurrence
  • Transplantation, Homologous
  • United States

Substances

  • Antineoplastic Agents
  • Interferon-alpha